FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306173832> ?p ?o ?g. }

• W4306173832 endingPage "41" @default.
• W4306173832 startingPage "33" @default.
• W4306173832 abstract "BackgroundKetone bodies are endogenous fuels produced by the liver under conditions of metabolic or neurohormonal stress. Circulating ketone bodies are increased in patients with chronic heart failure (HF), yet little is known about the effect of acute HF on ketosis. We tested the hypothesis that ketogenesis is increased in patients with acute decompensated HF.Methods and resultsThis was a post hoc analysis of 79 patients with acute HF included in the EMPA-RESPONSE-AHF trial, which compared sodium-dependent glucose-cotransporter protein 2 inhibitor treatment with empagliflozin for 30 days with placebo in patients with acute HF [NCT03200860]. Plasma concentrations of ketone bodies acetone, β-hydroxybutyrate, and acetoacetate were measured at baseline and 5 different timepoints. Changes in ketone bodies over time were monitored using repeated measures analysis of variance. In the total cohort, median total ketone body concentration was 251 µmol/L (interquartile range, 178–377 µmol/L) at baseline, which gradually decreased to 202 µmol/L (interquartile range, 156–240 µmol/L) at day 30 (P = .041). Acetone decreased from 60 µmol/L (interquartile range, 34–94 µmol/L) at baseline to 30 µmol/L (interquartile range, 21–42 µmol/L) ( P < .001), whereas β-hydroxybutyrate and acetoacetate remained stable over time. Higher acetone concentrations were correlated with higher N-terminal pro brain natriuretic peptide levels (r = 0.234; P = .039). Circulating ketone bodies did not differ between patients treated with empagliflozin or placebo throughout the study period. A higher acetone concentration at baseline was univariately associated with a greater risk of the composite end point, including in-hospital worsening HF, HF rehospitalizations, and all-cause mortality after 30 days. However, after adjustment for age and sex, acetone did not remain an independent predictor for the combined end point.ConclusionsCirculating ketone body concentrations, and acetone in particular, were significantly higher during an episode of acute decompensated HF compared with after stabilization. Treatment with empagliflozin did not affect ketone body concentrations in patients with acute HF." @default.
• W4306173832 created "2022-10-14" @default.
• W4306173832 creator A5005538765 @default.
• W4306173832 creator A5011446242 @default.
• W4306173832 creator A5021967917 @default.
• W4306173832 creator A5031658795 @default.
• W4306173832 creator A5041851398 @default.
• W4306173832 creator A5044048234 @default.
• W4306173832 creator A5051270747 @default.
• W4306173832 creator A5059047444 @default.
• W4306173832 creator A5069496306 @default.
• W4306173832 creator A5074566771 @default.
• W4306173832 creator A5090840024 @default.
• W4306173832 date "2023-01-01" @default.
• W4306173832 modified "2023-09-23" @default.
• W4306173832 title "Longitudinal Changes in Circulating Ketone Body Levels in Patients With Acute Heart Failure: A Post Hoc Analysis of the EMPA-Response-AHF Trial" @default.
• W4306173832 cites W2018308829 @default.
• W4306173832 cites W2025481353 @default.
• W4306173832 cites W2058928286 @default.
• W4306173832 cites W2071518542 @default.
• W4306173832 cites W2084419627 @default.
• W4306173832 cites W2127500778 @default.
• W4306173832 cites W2274126817 @default.
• W4306173832 cites W2341611738 @default.
• W4306173832 cites W2581663237 @default.
• W4306173832 cites W2595671027 @default.
• W4306173832 cites W2793459526 @default.
• W4306173832 cites W2804315085 @default.
• W4306173832 cites W2904132659 @default.
• W4306173832 cites W2913394347 @default.
• W4306173832 cites W2925036255 @default.
• W4306173832 cites W2936593438 @default.
• W4306173832 cites W2943018721 @default.
• W4306173832 cites W2943788550 @default.
• W4306173832 cites W2957825956 @default.
• W4306173832 cites W3000647500 @default.
• W4306173832 cites W3001210233 @default.
• W4306173832 cites W3003663516 @default.
• W4306173832 cites W3007564254 @default.
• W4306173832 cites W3081830235 @default.
• W4306173832 cites W3088992510 @default.
• W4306173832 cites W3092932642 @default.
• W4306173832 cites W3100542962 @default.
• W4306173832 cites W3116315343 @default.
• W4306173832 cites W3193297191 @default.
• W4306173832 cites W3198419784 @default.
• W4306173832 cites W3204781355 @default.
• W4306173832 cites W3212072078 @default.
• W4306173832 cites W4281295871 @default.
• W4306173832 cites W4294817235 @default.
• W4306173832 doi "https://doi.org/10.1016/j.cardfail.2022.09.009" @default.
• W4306173832 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36244653" @default.
• W4306173832 hasPublicationYear "2023" @default.
• W4306173832 type Work @default.
• W4306173832 citedByCount "3" @default.
• W4306173832 countsByYear W43061738322023 @default.
• W4306173832 crossrefType "journal-article" @default.
• W4306173832 hasAuthorship W4306173832A5005538765 @default.
• W4306173832 hasAuthorship W4306173832A5011446242 @default.
• W4306173832 hasAuthorship W4306173832A5021967917 @default.
• W4306173832 hasAuthorship W4306173832A5031658795 @default.
• W4306173832 hasAuthorship W4306173832A5041851398 @default.
• W4306173832 hasAuthorship W4306173832A5044048234 @default.
• W4306173832 hasAuthorship W4306173832A5051270747 @default.
• W4306173832 hasAuthorship W4306173832A5059047444 @default.
• W4306173832 hasAuthorship W4306173832A5069496306 @default.
• W4306173832 hasAuthorship W4306173832A5074566771 @default.
• W4306173832 hasAuthorship W4306173832A5090840024 @default.
• W4306173832 hasBestOaLocation W43061738322 @default.
• W4306173832 hasConcept C119060515 @default.
• W4306173832 hasConcept C126322002 @default.
• W4306173832 hasConcept C134018914 @default.
• W4306173832 hasConcept C142724271 @default.
• W4306173832 hasConcept C164705383 @default.
• W4306173832 hasConcept C204787440 @default.
• W4306173832 hasConcept C27081682 @default.
• W4306173832 hasConcept C2775887513 @default.
• W4306173832 hasConcept C2777180221 @default.
• W4306173832 hasConcept C2778198053 @default.
• W4306173832 hasConcept C31532488 @default.
• W4306173832 hasConcept C555293320 @default.
• W4306173832 hasConcept C62231903 @default.
• W4306173832 hasConcept C71924100 @default.
• W4306173832 hasConcept C78085059 @default.
• W4306173832 hasConcept C84693403 @default.
• W4306173832 hasConceptScore W4306173832C119060515 @default.
• W4306173832 hasConceptScore W4306173832C126322002 @default.
• W4306173832 hasConceptScore W4306173832C134018914 @default.
• W4306173832 hasConceptScore W4306173832C142724271 @default.
• W4306173832 hasConceptScore W4306173832C164705383 @default.
• W4306173832 hasConceptScore W4306173832C204787440 @default.
• W4306173832 hasConceptScore W4306173832C27081682 @default.
• W4306173832 hasConceptScore W4306173832C2775887513 @default.
• W4306173832 hasConceptScore W4306173832C2777180221 @default.
• W4306173832 hasConceptScore W4306173832C2778198053 @default.
• W4306173832 hasConceptScore W4306173832C31532488 @default.
• W4306173832 hasConceptScore W4306173832C555293320 @default.
• W4306173832 hasConceptScore W4306173832C62231903 @default.

• next